A combination of provirus stimulants with blockers of regulators of complement activation represents a novel approach for purging HIV-1 latently infected cells

被引：0
|
作者：
Lan, Jie [1 ,2 ]
Byrd, Daniel [1 ,2 ]
Amet, Tohti [1 ,2 ]
Yu, Qigui [1 ,2 ,3 ]
机构：
[1] Indiana Univ, Sch Med, Ctr AIDS Res, Indianapolis, IN USA
[2] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Div Infect Dis, Indianapolis, IN USA
来源：
JOURNAL OF IMMUNOLOGY | 2013年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P6342
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Identification of proximal biomarkers of PKC agonist activity in HIV-1 latently infected cells
    Vemula, Sai Vikram
    Maxwell, Jill
    Webber, Andrea
    Nefedov, Alexey
    Newhard, William
    Barnard, Richard
    Blair, Wade
    Hazuda, Daria
    Howell, Bonnie
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 : 71 - 71
  • [32] NOVEL INDOLOCARBAZOLE PROTEIN-KINASE-C INHIBITORS PREVENT REACTIVATION OF HIV-1 IN LATENTLY INFECTED-CELLS
    PATZOLD, S
    SCHNEIDER, J
    RUDOLPH, C
    MARME, D
    SCHACHTELE, C
    ANTIVIRAL RESEARCH, 1993, 22 (04) : 273 - 283
  • [33] HIV-1 EXPRESSION INDUCED BY ANTICANCER AGENTS IN LATENTLY HIV-1-INFECTED ACH2 CELLS
    OBRIEN, MC
    UENO, T
    JAHAN, N
    ZAJAC-KAYE, M
    MITSUYA, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (03) : 903 - 909
  • [34] Interleukin-10 enhances tumor necrosis factor-α activation of HIV-1 transcription in latently infected T cells
    Rabbi, MF
    Finnegan, A
    Al-Harthi, L
    Song, S
    Roebuck, KA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 19 (04): : 321 - 331
  • [35] Activation of HIV-1 expression in latently infected CD4+T cells by the small molecule PKC412
    Ao, Zhujun
    Zhu, Rong
    Tan, Xiaoli
    Liu, Lisa
    Chen, Liyu
    Liu, Shuiping
    Yao, XiaoJian
    VIROLOGY JOURNAL, 2016, 13
  • [36] The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure
    Ranganath, Nischal
    Sandstrom, Teslin S.
    Schinkel, Stephanie C. Burke
    Cote, Sandra C.
    Angel, Jonathan B.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (05): : 721 - 730
  • [37] INHIBITION OF HIV-1 EXPRESSION IN LATENTLY AND CHRONICALLY INFECTED-CELLS BY EXPERIMENTAL THERAPEUTIC COMPOUNDS
    BUTERA, ST
    ROBERTS, BD
    FOLKS, TM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S24 - S24
  • [38] IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis
    Raposo, Rui Andre Saraiva
    Rougvie, Miguel de Mulder
    Paquin-Proulx, Dominic
    Brailey, Phillip M.
    Cabido, Vinicius D.
    Zdinak, Paul M.
    Thomas, Allison S.
    Huang, Szu-han
    Beckerle, Greta A.
    Jones, Richard B.
    Nixon, Douglas F.
    JCI INSIGHT, 2017, 2 (01):
  • [39] Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412
    Zhujun Ao
    Rong Zhu
    Xiaoli Tan
    Lisa Liu
    Liyu Chen
    Shuiping Liu
    XiaoJian Yao
    Virology Journal, 13
  • [40] Genome-wide analysis of histone modifications in latently HIV-1 infected T cells
    Park, Jihwan
    Lim, Chae Hyun
    Ham, Seokjin
    Kim, Sung Soon
    Choi, Byeong-Sun
    Roh, Tae-Young
    AIDS, 2014, 28 (12) : 1719 - 1728
12345